MyBlueDotsMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MyBlueDots4 weeks ago01 mins FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Go to Source Author: Post navigation Previous: Mettler-Toledo International Inc. to Host Fourth Quarter 2024 Earnings Conference CallNext: Clinical trial highlights promising new treatment for intestinal worms
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots8 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots8 hours ago 0